Skip to main content
. 2010 Aug 11;31(2):606–613. doi: 10.1038/jcbfm.2010.130

Figure 1.

Figure 1

Experimental design. Three different sets of experiments were performed—assays for changes in endogenous α-MSH levels after MCAO (A), determination of neuroprotective and immunomodulatory effects at 24 hours (B), and assessment of long-term outcomes (C).